| The changing face of Klebsiella pneumoniae infections in the community Y Keynan, E Rubinstein International journal of antimicrobial agents 30 (5), 385-389, 2007 | 231 | 2007 |
| Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant DK Pomakova, CB Hsiao, JM Beanan, R Olson, U MacDonald, Y Keynan, ... European journal of clinical microbiology & infectious diseases 31, 981-989, 2012 | 211 | 2012 |
| Capsular Polysaccharide Synthesis Regions in Klebsiella pneumoniae Serotype K57 and a New Capsular Serotype YJ Pan, HC Fang, HC Yang, TL Lin, PF Hsieh, FC Tsai, Y Keynan, ... Journal of clinical microbiology 46 (7), 2231-2240, 2008 | 211 | 2008 |
| Vancomycin revisited–60 years later E Rubinstein, Y Keynan Frontiers in public health 2, 77697, 2014 | 206 | 2014 |
| Invariant NKT cells: regulation and function during viral infection JA Juno, Y Keynan, KR Fowke Public Library of Science 8 (8), e1002838, 2012 | 200 | 2012 |
| Swimming-induced pulmonary edema: clinical presentation and serial lung function Y Adir, A Shupak, A Gil, N Peled, Y Keynan, L Domachevsky, ... Chest 126 (2), 394-399, 2004 | 171 | 2004 |
| Validated risk score for predicting 6‐month mortality in infective endocarditis LP Park, VH Chu, G Peterson, A Skoutelis, T Lejko‐Zupa, E Bouza, ... Journal of the American Heart Association 5 (4), e003016, 2016 | 140 | 2016 |
| Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial K Ali, T Azher, M Baqi, A Binnie, S Borgia, FM Carrier, YA Cavayas, ... Cmaj 194 (7), E242-E251, 2022 | 136 | 2022 |
| Neutrophils-related host factors associated with severe disease and fatality in patients with influenza infection BM Tang, M Shojaei, S Teoh, A Meyers, J Ho, TB Ball, Y Keynan, ... Nature communications 10 (1), 3422, 2019 | 131 | 2019 |
| The role of regulatory T cells in chronic and acute viral infections Y Keynan, CM Card, PJ McLaren, MR Dawood, K Kasper, KR Fowke Clinical infectious diseases 46 (7), 1046-1052, 2008 | 124 | 2008 |
| A novel immune biomarker IFI27 discriminates between influenza and bacteria in patients with suspected respiratory infection BM Tang, M Shojaei, GP Parnell, S Huang, M Nalos, S Teoh, K O'Connor, ... European respiratory journal 49 (6), 2017 | 118 | 2017 |
| Impact of Early Valve Surgery on Outcome of Staphylococcus aureus Prosthetic Valve Infective Endocarditis: Analysis in the International Collaboration of … C Chirouze, F Alla, VG Fowler Jr, DJ Sexton, GR Corey, VH Chu, A Wang, ... Clinical Infectious Diseases 60 (5), 741-749, 2015 | 116 | 2015 |
| Simulating the effect of school closure during COVID-19 outbreaks in Ontario, Canada E Abdollahi, M Haworth-Brockman, Y Keynan, JM Langley, SM Moghadas BMC medicine 18, 1-8, 2020 | 99 | 2020 |
| Staphylococcus aureus bacteremia, risk factors, complications, and management Y Keynan, E Rubinstein Critical care clinics 29 (3), 547-562, 2013 | 87 | 2013 |
| The microbiology of endophthalmitis: global trends and a local perspective Y Keynan, Y Finkelman, P Lagacé-Wiens European journal of clinical microbiology & infectious diseases 31, 2879-2886, 2012 | 78 | 2012 |
| Pyogenic liver abscess caused by hypermucoviscous Klebsiella pneumoniae Y Keynan, JA Karlowsky, T Walus, E Rubinstein Scandinavian journal of infectious diseases 39 (9), 828-830, 2007 | 73 | 2007 |
| Vancomycin-resistant enterococci E Rubinstein, Y Keynan Critical care clinics 29 (4), 841-852, 2013 | 70 | 2013 |
| Pathophysiology of infective endocarditis Y Keynan, E Rubinstein Current infectious disease reports 15, 342-346, 2013 | 64 | 2013 |
| Chemokine receptor 5 Δ32 allele in patients with severe pandemic (H1N1) 2009 Y Keynan, J Juno, A Meyers, TB Ball, A Kumar, E Rubinstein, KR Fowke Emerging infectious diseases 16 (10), 1621, 2010 | 64 | 2010 |
| Reactive arthritis--the appropriate name Y Keynan, D Rimar The Israel Medical Association Journal 10 (4), 256, 2008 | 55 | 2008 |
